Oral Dissolving Film Market Size, Trends and Outlook for 2023-2031 - Benzinga
| IGXT Stock | USD 0.17 0.00 0.00% |
Slightly above 56% of Intelgenx Technologs' investor base is looking to short. The analysis of overall sentiment of trading Intelgenx Technologs pink sheet suggests that many investors are alarmed at this time. Intelgenx Technologs' investing sentiment can be driven by a variety of factors including economic data, Intelgenx Technologs' earnings reports, geopolitical events, and overall market trends.
Intelgenx |
Oral Dissolving Film Market Size, Trends and Outlook for 2023-2031 Benzinga
Read at news.google.com
 |
Intelgenx Technologs Fundamental Analysis
We analyze Intelgenx Technologs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelgenx Technologs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelgenx Technologs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Intelgenx Technologs is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Intelgenx Technologs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intelgenx Technologs pink sheet to make a market-neutral strategy. Peer analysis of Intelgenx Technologs could also be used in its relative valuation, which is a method of valuing Intelgenx Technologs by comparing valuation metrics with similar companies.
Peers
Intelgenx Technologs Related Equities
| ASCLF | Ascletis Pharma | 33.33 | ||||
| MNPR | Monopar Therapeutics | 4.12 | ||||
| ELDN | Eledon Pharmaceuticals | 4.03 | ||||
| CADL | Candel Therapeutics | 2.92 | ||||
| ACXP | Acurx Pharmaceuticals | 1.51 | ||||
| NUVB | Nuvation Bio | 1.49 | ||||
| ETON | Eton Pharmaceuticals | 0.00 | ||||
| FENC | Fennec Pharmaceuticals | 0.83 | ||||
| ABOS | Acumen Pharmaceuticals | 1.02 | ||||
| PMVP | Pmv Pharmaceuticals | 1.92 | ||||
| CNTB | Connect Biopharma | 2.68 | ||||
| VRCA | Verrica Pharmaceuticals | 7.79 | ||||
| LRMR | Larimar Therapeutics | 11.59 |
Additional Tools for Intelgenx Pink Sheet Analysis
When running Intelgenx Technologs' price analysis, check to measure Intelgenx Technologs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelgenx Technologs is operating at the current time. Most of Intelgenx Technologs' value examination focuses on studying past and present price action to predict the probability of Intelgenx Technologs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelgenx Technologs' price. Additionally, you may evaluate how the addition of Intelgenx Technologs to your portfolios can decrease your overall portfolio volatility.